1. Home
  2. VABK vs BIOA Comparison

VABK vs BIOA Comparison

Compare VABK & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VABK

Virginia National Bankshares Corporation

HOLD

Current Price

$54.30

Market Cap

265.4M

Sector

Finance

ML Signal

HOLD

Logo BioAge Labs Inc.

BIOA

BioAge Labs Inc.

HOLD

Current Price

$5.56

Market Cap

255.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VABK
BIOA
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.4M
255.6M
IPO Year
2013
2024

Fundamental Metrics

Financial Performance
Metric
VABK
BIOA
Price
$54.30
$5.56
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
★ $32.56
AVG Volume (30 Days)
15.7K
★ 774.7K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
★ 2.71%
N/A
EPS Growth
12.70
★ 66.21
EPS
★ 2.62
N/A
Revenue
N/A
★ $8,995,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$97.72
P/E Ratio
$20.44
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.35
$4.81
52 Week High
$54.33
$25.96

Technical Indicators

Market Signals
Indicator
VABK
BIOA
Relative Strength Index (RSI) 65.58 44.87
Support Level $46.61 $4.81
Resistance Level N/A $8.53
Average True Range (ATR) 1.72 0.44
MACD 0.29 0.22
Stochastic Oscillator 88.90 76.51

Price Performance

Historical Comparison
VABK
BIOA

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company engaged in commercial and retail banking. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts, and other depository services. Its segments include the Bank, VNB Trust and Estate Services, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits, and offering related services to individuals, businesses, and charitable organizations.

About BIOA BioAge Labs Inc.

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.

Share on Social Networks: